Other strategies known to induce strong CD8 T cell responses use vectors given in heterologous prime‐boost strategies and have been successful in inducing functional cure in animal models of chronic hepatitis B (115, 131, 132). Here, CD8A is linked to chronic hepatitis B virus infection.